| Adenocarcinoma (12) |  |
| Brain tumor (84) | |
| Carcinoma (22) | |
| Cyst (9) | |
| Glioma (48) | |
| Malignant tumor (7) | |
| Melanoma (178) | |
| Meningioma (6) | |
| Mesothelioma (5) | |
| Tumor (1275) | |
| Adenocarcinoma (12) | |
| Brain tumor (84) | |
| Carcinoma (22) | |
| Cyst (9) | |
| Glioma (48) | |
| Malignant tumor (7) | |
| Melanoma (178) | |
| Meningioma (6) | |
| Mesothelioma (5) | |
| Tumor (1275) | |
In this study the researchers focused on a type of non-small cell lung cancer called lung adenocarcinoma
Jacks lab has engineered previously mice that conditionally express the Kras oncogene only in the lung leading them to develop lung adenocarcinoma.
It is almost always found in people with a specific type of NSCLC called adenocarcinoma.
we believe that the enzyme might serve as a potential drug target in KRAS-dependent lung adenocarcinoma,
though the role of these mutations has not been understood well in lung cancer (especially adenocarcinoma, which makes up almost a quarter of all lung cancers).
From the Cancer Genome Atlas data, the Salk team found that genetic alterations of Epha2 were detected in 54 out of 230 patients with adenocarcinoma.
The scientists settled on just three proteins after conducting proteomic analyses of 488 urine samples92 from patients with pancreatic ductal adenocarcinoma (PDAC
The panel performance was described August 3 in the journal Clinical Cancer Research, in an article entitled, dentification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma. hen comparing
"The study reveals the most rigorously validated classification system for pancreatic ductal adenocarcinoma to date. Previous studies,
1) human prostate cancer cell lines and normal prostate epithelial cells,(2) prostate adenocarcinoma tissue samples and matched normal tissue samples,(3) urine samples
expression of SPRY-IT1 was found to be increased in 16 of 18 (89 percent) tissue samples from patients with prostatic adenocarcinoma,
Intense staining was seen in all adenocarcinoma samples, but not in normal prostatic tissue. Finally, the investigators showed that reduction of SPRY4-IT1 in prostate cancer cells through the use of small interfering RNA (sirna) leads to decreased cell viability and cellular invasion as well as increased apoptosis similar to
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011